Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHEK2 pseudogene 1 (CHEK2P1) is a non-functional DNA segment closely related to the CHEK2 gene. While the CHEK2 gene encodes checkpoint kinase 2—a serine/threonine kinase essential for cell cycle checkpoint control, DNA repair, and tumor suppression—CHEK2P1 does not produce a functional protein. Because of high sequence homology, CHEK2P1 can be amplified in genetic studies by accident and confound CHEK2 variant analysis[5]. Pseudogenes such as CHEK2P1 can be mistaken for their parent gene and are generally not considered therapeutically relevant[4][5]. CHEK2P1 should not be confused with **CHEK2 (checkpoint kinase 2)**, whose protein product plays a critical role in the DNA damage response and is a validated biomarker and disease-associated gene for multiple cancers[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CHEK2 pseudogene 1 (CHEK2P1).